Enrocare 100 mg/ml Solution for Injection for Cattle and Pigs
Enrocare 100 mg/ml Solution for Injection for Cattle and Pigs
Authorised
- Enrofloxacin
Product identification
Medicine name:
Enrocare 100 mg/ml Solution for Injection for Cattle and Pigs
Active substance:
- Enrofloxacin
Target species:
-
Pig
-
Cattle
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Enrofloxacin100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal13day
-
-
-
Intravenous use
-
Cattle
-
Meat and offal5day
-
Milk3day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal12day
-
Milk4day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vial sold in packs containing 1 x 100 ml cartons.
- 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vial sold in packs containing 6 x 100 ml cartons.
- 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vial sold in packs containing 12 x 100 ml cartons.
- 250 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.250 ml vial sold in packs containing 1 x 250 ml cartons.
- 250 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.250 ml vial sold in packs containing 6 x 250 ml cartons.
- 250 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.250 ml vial sold in packs containing 12 x 250 ml cartons.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 104354
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0455/003
Concerned member states:
-
Luxembourg
-
Netherlands
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 26/01/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024